Serum phosphorus in people with chronic kidney disease: you are what you eat
- PMID: 24172733
- DOI: 10.1038/ki.2013.258
Serum phosphorus in people with chronic kidney disease: you are what you eat
Abstract
This issue of Kidney International includes two important articles about serum phosphorus and its treatment. The article by Cannata-Andía and colleagues describes a rigorous observational study of the association between serum phosphorus level, phosphate binder use, and clinical outcomes including all-cause and cardiovascular mortality. The article by Mehrotra and colleagues addresses the association between serum phosphorus, socioeconomic status, and mortality among participants in the US-based KEEP program.
Comment on
-
No independent association of serum phosphorus with risk for death or progression to end-stage renal disease in a large screen for chronic kidney disease.Kidney Int. 2013 Nov;84(5):989-97. doi: 10.1038/ki.2013.145. Epub 2013 Apr 24. Kidney Int. 2013. PMID: 23615501 Free PMC article.
-
Use of phosphate-binding agents is associated with a lower risk of mortality.Kidney Int. 2013 Nov;84(5):998-1008. doi: 10.1038/ki.2013.185. Epub 2013 Jul 3. Kidney Int. 2013. PMID: 23823605
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical